title: Therapy for adolescent and adult acute lymphoblastic leukemia: randomization of induction and consolidation therapies (preliminary results of EORTC Study 58791).
authors.forename: P
authors.initials: P
authors.lastname: Stryckmans
authors.forename: J P
authors.initials: JP
authors.lastname: Marie
authors.forename: S
authors.initials: S
authors.lastname: Suciu
authors.forename: G
authors.initials: G
authors.lastname: Solbu
authors.forename: L
authors.initials: L
authors.lastname: Debusscher
authors.forename: J
authors.initials: J
authors.lastname: Bury
authors.forename: M
authors.initials: M
authors.lastname: Peetermans
authors.forename: J M
authors.initials: JM
authors.lastname: Andrien
authors.forename: D
authors.initials: D
authors.lastname: Fière
authors.forename: C
authors.initials: C
authors.lastname: Cauchie
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005060:Europe; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008727:Methotrexate / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D011379:Prognosis; D011897:Random Allocation; D012074:Remission Induction; D013866:Thioguanine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D014750:Vincristine; D004317:Doxorubicin; D013866:Thioguanine; D011241:Prednisone; D008727:Methotrexate